&srotate=0)
semaglutide vs tirzepatide compound Compounded Semaglutide/Tirzepatide: Personalized, Affordable Medical Weight Loss ✨ Semaglutide vs. Tirzepatide —
Description
Month-over-month ADM prescribing increased in April and May 2024 then decreased slightly in June 2024
The long half-life means timing flexibility is high
You are on the lowest starting dose, which is intentionally subtherapeutic for weight loss
The identity layer covers CAS 2023788-19-2, formula C225H348N48O68, 4813 Da molecular weight
I have seen a case of that in our clinic
What does this mean for GP practices and PCNs
